MAPT and Alzheimer disease: Also due to budget constraint, we do not include determination of specific biomarkers for Alzheimer’s disease in spinal fluid and with PET (Pet amyloid and tau) [117], nevertheless we store blood sample that will allow to study blood-based biomarkers when available.